Keywords
Affiliated Institutions
Related Publications
Clinical and immunological features of severe and moderate coronavirus disease 2019
BACKGROUNDSince December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and is...
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
What happens next? Four months into the severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) outbreak, we still do not know enough about postrecovery immune protection a...
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Variable memory Immune memory against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) helps to determine protection against reinfection, disease risk, and vaccine e...
COVID-19 infection: the perspectives on immune responses
More than 100 years since the outbreak of the 1918 influenza pandemic, we now seem to face another pandemic. The outbreak of the new coronavirus (SARS-CoV-2) infection is spread...
SARS-CoV-2 vaccines in development
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late 2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) pande...
Publication Info
- Year
- 2020
- Type
- review
- Volume
- 52
- Issue
- 5
- Pages
- 737-741
- Citations
- 1180
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1016/j.immuni.2020.04.012